“Harassment thrives in settings dominated by men,” write Dis, Stadum, and Choo in a Harvard Business Review article […]
The EU Clinical Trials Regulation is set to come into effect on 31 January 2022 and will include […]
Coronavirus infections in England were at their highest ever rate in early January this year, with an estimated […]
I am confused about how creating a public repository that sets out consultants’ practising privileges “including how many […]
COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for […]
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments
Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ dismay at Roche’s Spark aliu Wed, 01/26/2022 – […]
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50% fkansteiner Wed, 01/26/2022 – 11:04
Immunocore wins FDA nod for first uveal melanoma treatment, also first T-cell receptor therapeutic kdunleavy Wed, 01/26/2022 – […]
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger fkansteiner Wed, 01/26/2022 […]